Stocks
Vertex Pharmaceuticals IncorporatedVRTX
NASDAQHealthcareBiotechnology$469.34-1.84%
A biotechnology company focused on developing therapies for serious genetic diseases, with a dominant portfolio of treatments for cystic fibrosis that generate the majority of its revenue. The company is expanding its pipeline into areas such as gene-editing therapies, pain management, and other rar...
Market Cap: $119.2B52W Range: $362.50 – $517.20
This page tracks all publicly disclosed congressional trades in Vertex Pharmaceuticals Incorporated (VRTX), a company in the Healthcare sector. 12 members of Congress have disclosed trades in this stock, including 23 purchases and 27 sales. All data is sourced from STOCK Act Periodic Transaction Reports filed with the House and Senate disclosure offices.
Total Disclosures
50
Unique Politicians
12
Buys
23
Sells
27
Congressional Trading History
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2026-02-05 | Rohit Khanna | buy | $1K – $15K |
| 2026-01-29 | Rohit Khanna | sell | $15K – $50K |